JOINT CORP/THE (JYNT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:JYNT • US47973J1025

10.03 USD
-0.08 (-0.79%)
At close: Feb 3, 2026
10.03 USD
0 (0%)
After Hours: 2/3/2026, 8:28:05 PM
Fundamental Rating

4

Overall JYNT gets a fundamental rating of 4 out of 10. We evaluated JYNT against 102 industry peers in the Health Care Providers & Services industry. While JYNT has a great health rating, there are worries on its profitability. JYNT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • JYNT had negative earnings in the past year.
  • JYNT had a positive operating cash flow in the past year.
  • In multiple years JYNT reported negative net income over the last 5 years.
  • Each year in the past 5 years JYNT had a positive operating cash flow.
JYNT Yearly Net Income VS EBIT VS OCF VS FCFJYNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

  • JYNT has a Return On Assets of -1.40%. This is comparable to the rest of the industry: JYNT outperforms 44.12% of its industry peers.
  • JYNT has a Return On Equity (-4.27%) which is in line with its industry peers.
Industry RankSector Rank
ROA -1.4%
ROE -4.27%
ROIC N/A
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
JYNT Yearly ROA, ROE, ROICJYNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

  • JYNT's Gross Margin of 78.26% is amongst the best of the industry. JYNT outperforms 93.14% of its industry peers.
  • In the last couple of years the Gross Margin of JYNT has declined.
  • The Profit Margin and Operating Margin are not available for JYNT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
JYNT Yearly Profit, Operating, Gross MarginsJYNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

7

2. Health

2.1 Basic Checks

  • JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • JYNT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, JYNT has more shares outstanding
  • JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
JYNT Yearly Shares OutstandingJYNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
JYNT Yearly Total Debt VS Total AssetsJYNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • JYNT has an Altman-Z score of 3.05. This indicates that JYNT is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.05, JYNT is in the better half of the industry, outperforming 63.73% of the companies in the same industry.
  • There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.05
ROIC/WACCN/A
WACC8.93%
JYNT Yearly LT Debt VS Equity VS FCFJYNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
  • The Current ratio of JYNT (1.83) is better than 72.55% of its industry peers.
  • A Quick Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.83, JYNT is doing good in the industry, outperforming 75.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.83
JYNT Yearly Current Assets VS Current LiabilitesJYNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

2

3. Growth

3.1 Past

  • JYNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.03%, which is quite impressive.
  • JYNT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.15%.
  • JYNT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.36% yearly.
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%

3.2 Future

  • The Earnings Per Share is expected to grow by 44.54% on average over the next years. This is a very strong growth
  • JYNT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -22.13% yearly.
EPS Next Y83%
EPS Next 2Y95.15%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue Next Year-54.9%
Revenue Next 2Y-31.56%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JYNT Yearly Revenue VS EstimatesJYNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
JYNT Yearly EPS VS EstimatesJYNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for JYNT. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 25.21 indicates a quite expensive valuation of JYNT.
  • JYNT's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 25.51. JYNT is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 25.21
JYNT Price Earnings VS Forward Price EarningsJYNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800 -1K

4.2 Price Multiples

  • JYNT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 91.36
EV/EBITDA N/A
JYNT Per share dataJYNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • JYNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as JYNT's earnings are expected to grow with 44.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y95.15%
EPS Next 3Y44.54%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for JYNT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

JOINT CORP/THE

NASDAQ:JYNT (2/3/2026, 8:28:05 PM)

After market: 10.03 0 (0%)

10.03

-0.08 (-0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)03-11
Inst Owners78.47%
Inst Owner Change-0.53%
Ins Owners22.97%
Ins Owner Change2.68%
Market Cap149.15M
Revenue(TTM)91.63M
Net Income(TTM)-970.20K
Analysts76
Price Target10.88 (8.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.07%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-14.21%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)-1.53%
Revenue beat(8)3
Avg Revenue beat(8)-6.24%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)5
Avg Revenue beat(16)-4.04%
PT rev (1m)-0.77%
PT rev (3m)-28.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.29%
EPS NY rev (1m)-12.83%
EPS NY rev (3m)-1366.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.2%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-1.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.21
P/S 1.63
P/FCF 91.36
P/OCF 48.56
P/B 6.57
P/tB 6.57
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)0.4
Fwd EY3.97%
FCF(TTM)0.11
FCFY1.09%
OCF(TTM)0.21
OCFY2.06%
SpS6.16
BVpS1.53
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.4%
ROE -4.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.26%
FCFM 1.78%
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 78.79%
Cap/Sales 1.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.83
Altman-Z 3.05
F-Score6
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
EPS Next Y83%
EPS Next 2Y95.15%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
Revenue Next Year-54.9%
Revenue Next 2Y-31.56%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
EBIT growth 1Y-575.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year312.75%
EBIT Next 3Y60.95%
EBIT Next 5YN/A
FCF growth 1Y-85.24%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-81.35%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%

JOINT CORP/THE / JYNT FAQ

What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to JYNT.


Can you provide the valuation status for JOINT CORP/THE?

ChartMill assigns a valuation rating of 3 / 10 to JOINT CORP/THE (JYNT). This can be considered as Overvalued.


How profitable is JOINT CORP/THE (JYNT) stock?

JOINT CORP/THE (JYNT) has a profitability rating of 3 / 10.


How financially healthy is JOINT CORP/THE?

The financial health rating of JOINT CORP/THE (JYNT) is 7 / 10.